Biodelivery Sciences International

Great News! Now you can buy fractional shares of Biodelivery Sciences International

What is Fractional Shares?

Fractional shares are pieces of one full share of a company or exchange-traded fund (ETF).

In INDmoney, you can buy Biodelivery Sciences International stock in any dollar amount, or any other stock you want.

$10

$50

$100

BDSI

Biodelivery Sciences International (BDSI)

Q: Can Indians buy Biodelivery Sciences International (BDSI) shares?

Yes, Indians can buy Biodelivery Sciences International (BDSI) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy Biodelivery Sciences International (BDSI) shares from India?

Three ways to invest in Biodelivery Sciences International (BDSI) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in Biodelivery Sciences International (BDSI) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of Biodelivery Sciences International (BDSI) be purchased?

You can buy just a fraction of Biodelivery Sciences International (BDSI) shares.

Q: What are the documents required to start investing in Biodelivery Sciences International (BDSI) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in Biodelivery Sciences International (BDSI) stocks . The entire process is paperless and can be completed seamlessly.

$3.186%▲

Key Stats

Open	$3.04
Today Low/High	$3.03 / $3.34
52 Week Low/High	$2.5 / $4.68
Market Cap	-

Company Details

BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.